Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12617000052336
Ethics application status
Approved
Date submitted
4/01/2017
Date registered
11/01/2017
Date last updated
29/03/2022
Date data sharing statement initially provided
29/03/2022
Type of registration
Prospectively registered
Titles & IDs
Public title
Observational study into the full cost of red cell transfusion in patients with beta thalassaemia at Monash Medical Centre
Query!
Scientific title
Observational study into the full cost of red cell transfusion in patients with beta thalassaemia at Monash Medical Centre
Query!
Secondary ID [1]
290835
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
TRUSTT
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Thalassaemia
301509
0
Query!
Condition category
Condition code
Blood
301222
301222
0
0
Query!
Other blood disorders
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
False
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
This study will determine the number and types of transfusions administered to patients with thalassaemia major treated at a single hospital (Monash Medical Centre) over a five month period (February to June 2017); and the total costs for providing those transfusions.
To do this detailed process maps will be developed by observing the process and validating process maps with hospital staff. Duplicate measures of the time taken for each process will be made.
Costs will be calculated using hospital financial information obtained from Monash Health financial and administrative databases, and from published data.
Indirect overhead costs such as administrative and general expenditures will be added as a percentage of the process costs. The percentage will be determined by Monash Health’s overall ratio between indirect costs and direct or operational costs.
Hospital records will be used to calculate the number and types of transfusions administered.
Query!
Intervention code [1]
296758
0
Not applicable
Query!
Comparator / control treatment
No control group
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
300632
0
Total cost of products and processes related to transfusion of a single unit of red cells in the thalassaemia clinic at MMC will be calculated using timings of observed processes and hospital clinical and financial records.
Query!
Assessment method [1]
300632
0
Query!
Timepoint [1]
300632
0
During the five month observation period from Feb-June 2017
Query!
Secondary outcome [1]
330460
0
Total cost of red cell products and processes for a single patient transfusion episode in the thalassaemia clinic at MMC will be calculated using timings of observed processes and hospital clinical and financial records.
Query!
Assessment method [1]
330460
0
Query!
Timepoint [1]
330460
0
During the five month observation period from Feb-June 2017
Query!
Secondary outcome [2]
330461
0
Total cost of products and processes for a year of patient red cell transfusion support in the thalassaemia clinic at MMC will be calculated using timings of observed processes and hospital clinical and financial records.
Query!
Assessment method [2]
330461
0
Query!
Timepoint [2]
330461
0
During the five month observation period from Feb-June 2017
Query!
Eligibility
Key inclusion criteria
The unit of observation is the process involved in preparation or administration of a unit of RBCs and as such, patients are not enrolled into this study.
The inclusion criteria relating to the patients whose treatment is observed are:
All patients undergoing red cell transfusion in the thalassaemia clinic at Monash Medical Centre between Feb 2017 and June 2017.
Query!
Minimum age
No limit
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
There are no exclusion criteria relating to the patients whose treatment is observed.
Query!
Study design
Purpose
Psychosocial
Query!
Duration
Cross-sectional
Query!
Selection
Convenience sample
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Data on process timings, resource requirements, staffing requirements and staffing levels will be collected on a convenience sample of a minimum of 3 episodes per process, with the average of the recorded episodes used. Where significant variability is identified in the timings of any given process, additional observations will be collected. Data on the costs associated with each process (including direct overhead costs) will be collected directly from Monash Health financial and administrative databases where available, and from published data otherwise (for example, NBA National Product Price List, MBS schedule, Victorian staffing awards). Indirect overhead costs such as administrative and general expenditures will be added as a percentage of the process costs. The percentage will be determined by Monash Health’s overall ratio between indirect costs and direct or operational costs. All costs will be expressed in Australian dollars
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/02/2017
Query!
Actual
1/04/2017
Query!
Date of last participant enrolment
Anticipated
30/06/2017
Query!
Actual
31/10/2017
Query!
Date of last data collection
Anticipated
31/08/2017
Query!
Actual
31/10/2017
Query!
Sample size
Target
3
Query!
Accrual to date
Query!
Final
3
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
7186
0
Monash Medical Centre - Clayton campus - Clayton
Query!
Recruitment postcode(s) [1]
14949
0
3168 - Clayton
Query!
Funding & Sponsors
Funding source category [1]
295257
0
Commercial sector/Industry
Query!
Name [1]
295257
0
Celgene Pty Limited
Query!
Address [1]
295257
0
Level 7, 607 St Kilda Rd,
Melbourne VIC 3004
Query!
Country [1]
295257
0
Australia
Query!
Primary sponsor type
University
Query!
Name
Monash University
Query!
Address
Wellington Road,
Clayton, VIC 3800
Query!
Country
Australia
Query!
Secondary sponsor category [1]
294087
0
None
Query!
Name [1]
294087
0
Query!
Address [1]
294087
0
Query!
Country [1]
294087
0
Query!
Other collaborator category [1]
279384
0
Hospital
Query!
Name [1]
279384
0
Monash Medical Centre
Query!
Address [1]
279384
0
246 Clayton Rd,
Clayton VIC 3168
Query!
Country [1]
279384
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
296595
0
Monash Health Human Research Ethics Low Risk Review panel
Query!
Ethics committee address [1]
296595
0
Level 2, I (icy) Block Monash Medical Centre 246 Clayton Rd Clayton Victoria 3168
Query!
Ethics committee country [1]
296595
0
Australia
Query!
Date submitted for ethics approval [1]
296595
0
20/06/2016
Query!
Approval date [1]
296595
0
18/11/2016
Query!
Ethics approval number [1]
296595
0
LNR/16/MonH/248
Query!
Summary
Brief summary
The aim of this study is to determine the total cost of administration of a unit of red blood cells for a patient with thalassaemia major treated at Monash Medical Centre, Melbourne, Australia. This study involves determination of the processes and costs associated with administering a unit of RBCs to adult patients with thalassaemia at Monash Medical Centre, Clayton, Victoria, Australia. The unit of observation is the process involved in preparation or administration of a unit of RBCs and as such, patients are not enrolled into this study. Transfusions can be life-saving, but they also carry risks and substantial costs. Alternatives to transfusions exist for some patients, but evaluations and decisions about treatment options are often complex, and may be more difficult when the benefits, risks and costs are not well characterised. Australian governments through the National Blood Authority (NBA) spend in the order of $AUD 1 billion annually in provision of blood products for the community. However, visibility of transfusion--related costs is generally low. The “manufacturing cost” is now carried on the blood product label, and for red blood cells (RBCs) at October 2015 this is $AUD 374.72(1). In some Australian states the costs of the product is devolved to the hospital level, but most hospitals have little or no idea of the true costs of transfusion therapy, over and above the costs of providing components, including laboratory and clinical costs. Thalassaemia is associated with significant complications and often requires lifelong therapy, involving red blood cell transfusion every three to four weeks which require the individual to attend hospital for the day. Estimates of the total healthcare costs for a beta thalassaemia major patient experiencing minimal complications are $150K per year, however there are currently no Australian transfusion costing data in the thalassaemia context. Understanding the full cost of transfusion will inform policy development and facilitate safe and cost effective treatments and transfusion support for patients with beta thalassaemia; resulting in improved outcomes for patients and better utilization of limited health resources.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
71430
0
A/Prof Erica Wood
Query!
Address
71430
0
Monash University
Department of Epidemiology and Preventive Medicine
The Alfred Centre
99 Commercial Road
Melbourne, VIC 3004
Query!
Country
71430
0
Australia
Query!
Phone
71430
0
+61 3 99030051
Query!
Fax
71430
0
+61 3 99030556
Query!
Email
71430
0
[email protected]
Query!
Contact person for public queries
Name
71431
0
Erica Wood
Query!
Address
71431
0
Monash University
Department of Epidemiology and Preventive Medicine
The Alfred Centre
99 Commercial Road
Melbourne, VIC 3004
Query!
Country
71431
0
Australia
Query!
Phone
71431
0
+61 3 99030051
Query!
Fax
71431
0
+61 3 99030556
Query!
Email
71431
0
[email protected]
Query!
Contact person for scientific queries
Name
71432
0
Zoe McQuilten
Query!
Address
71432
0
Monash University
Department of Epidemiology and Preventive Medicine
The Alfred Centre
99 Commercial Road
Melbourne, VIC 3004
Query!
Country
71432
0
Australia
Query!
Phone
71432
0
+61 3 99030379
Query!
Fax
71432
0
Query!
Email
71432
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Patient confidentiality
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF